It modulated melanoma cell metastasis by reducing MMP‐2 and MMP‐9 expression through the inhibition of the FAK/PI3K/Akt/mTOR, MAPK and GRB2 signalling pathways. This evidence concerns the gene MMP9 and melanoma.